Clinical Trial Update: Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the effects of imidapril and candesartan on fibrinolysis and insulin sensitivity in patients with essential hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Candesartan (candesartan)
• Imidapril (imidapril)

Snippet

Sponsor: University of Pavia | Conditions: Essential Hypertension | Phase 3 | Status: UNKNOWN